查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1905406

日本流感诊断市场报告（按产品、检测类型、流感类型、最终用户和地区划分，2026-2034年）

Japan Influenza Diagnostics Market Report by Product, Test Type, Type of Flu, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本流感诊断市场规模达6,660万美元。展望未来， IMARC Group预计到2034年，该市场规模将达到1.061亿美元，2026年至2034年间的复合年增长率（CAGR）为5.31%。推动市场成长的因素有很多，包括疫苗接种活动的扩大、即时检测的便利性、流感病毒研究的深入以及公共卫生倡议提高公众意识等。

本报告解答的关键问题：

  • 日本流感诊断市场目前表现如何？未来几年又将如何发展？
  • 新冠疫情对日本流感诊断市场产生了哪些影响？
  • 日本流感诊断市场依产品分類的组成是怎样的？
  • 日本流感诊断市场依检测类型分類的组成是怎样的？
  • 日本流感诊断市场以流感类型分類的组成是怎样的？
  • 日本流感诊断市场依最终用户分類的组成是怎样的？
  • 日本流感诊断市场价值链的各个阶段有哪些？
  • 日本流感诊断的关键驱动因素和挑战是什么？
  • 日本流感诊断市场的结构是怎么样的？主要参与者有哪些？
  • 日本流感诊断市场的竞争程度如何？

目录

第一章：序言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 数据来源
  • 市场估算
  • 预测方法

第三章：执行概要

第四章：日本流感诊断市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本流感诊断市场概况

  • 历史及当前市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本流感诊断市场－依产品细分

  • 测试盒和试剂
  • 仪器
  • 其他的

第七章：日本流感诊断市场－依检测类型划分

  • 分子诊断测试
  • 传统诊断测试

第八章：日本流感诊断市场－依流感类型划分

  • 甲型流感
  • 乙型流感
  • 丙型流感

第九章：日本流感诊断市场－以最终用户划分

  • 医院
  • 诊断实验室
  • 其他的

第十章：日本流感诊断市场－按地区划分

  • 关东地区
  • 关西/近畿地区
  • 中部/中部地区
  • 九州·冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十一章：日本流感诊断市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争格局分析
  • 公司评估象限

第十二章：关键参与者简介

第十三章：日本流感诊断市场－产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十四章：附录

简介目录
Product Code: SR112026A19551

Japan influenza diagnostics market size reached USD 66.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 106.1 Million by 2034, exhibiting a growth rate (CAGR) of 5.31% during 2026-2034. The market is being driven by several factors, including the expansion of vaccination campaigns, the convenience offered by point-of-care testing, intensified research into influenza viruses, and increased awareness through public health initiatives.

Influenza, commonly referred to as the flu, is a viral infection that primarily targets the respiratory system, affecting areas such as the nose, throat, and lungs. The realm of influenza diagnostics encompasses a variety of immunoassay tests designed to detect the presence of nucleoprotein antigens from influenza A and B viruses in respiratory samples. Among the available diagnostic methods are rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serological tests, and rapid molecular assays. These diagnostic options are relied upon by healthcare professionals to promptly identify and categorize influenza strains, facilitating effective treatment decisions and enabling efficient public health management.

Japan Influenza Diagnostics Market Trends:

The influenza diagnostics market in Japan is witnessing substantial growth, driven by a combination of factors. Foremost among these is the increasing incidence of flu outbreaks, which necessitates effective diagnostic solutions. Apart from this, the growing concerns regarding the potential for pandemics have spurred investments in diagnostic capabilities, making a significant contribution to market expansion. Furthermore, continuous technological advancements in the field are enhancing the accuracy and speed of diagnostic tests, positively impacting the market's growth trajectory. Besides this, public awareness campaigns focused on the importance of timely testing have encouraged more individuals to seek diagnostic services, further catalyzing market demand. Japan's rising healthcare spending supports the adoption of advanced diagnostic methods, contributing to market growth. Additionally, elderly individuals, who are more vulnerable to severe cases of the flu, are driving increased demand for diagnostic services. The growth of urban populations in Japan has led to higher infection rates, underscoring the need for robust diagnostic solutions. Frequent travel within the country and internationally has accelerated the spread of the flu, further highlighting the importance of efficient diagnostics. These factors will collectively create numerous opportunities for the influenza diagnostics market in Japan over the forecasted period.

Japan Influenza Diagnostics Market Segmentation:

Product Insights:

  • Test Kit and Reagents
  • Instruments
  • Others

Test Type Insights:

  • Molecular Diagnostic Tests
    • Polymerase Chain Reaction
    • Isothermal Nucleic Acid Amplification Tests
    • Others
  • Traditional Diagnostic Tests
    • Rapid Influenza Diagnostic Tests
    • Viral Culture Tests
    • Direct Fluorescent Antibody Test
    • Serological Tests

Type of Flu Insights:

  • Type A Flu
  • Type B Flu
  • Type C Flu

End User Insights:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan influenza diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan influenza diagnostics market?
  • What is the breakup of the Japan influenza diagnostics market on the basis of product?
  • What is the breakup of the Japan influenza diagnostics market on the basis of test type?
  • What is the breakup of the Japan influenza diagnostics market on the basis of type of flu?
  • What is the breakup of the Japan influenza diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan influenza diagnostics market?
  • What are the key driving factors and challenges in the Japan influenza diagnostics?
  • What is the structure of the Japan influenza diagnostics market and who are the key players?
  • What is the degree of competition in the Japan influenza diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Influenza Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Influenza Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Influenza Diagnostics Market - Breakup by Product

  • 6.1 Test Kit and Reagents
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Instruments
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Others
    • 6.3.1 Historical and Current Market Trends (2020-2025)
    • 6.3.2 Market Forecast (2026-2034)

7 Japan Influenza Diagnostics Market - Breakup by Test Type

  • 7.1 Molecular Diagnostic Tests
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Polymerase Chain Reaction
      • 7.1.3.2 Isothermal Nucleic Acid Amplification Tests
      • 7.1.3.3 Others
    • 7.1.4 Market Forecast (2026-2034)
  • 7.2 Traditional Diagnostic Tests
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Rapid Influenza Diagnostic Tests
      • 7.2.3.2 Viral Culture Tests
      • 7.2.3.3 Direct Fluorescent Antibody Test
      • 7.2.3.4 Serological Tests
    • 7.2.4 Market Forecast (2026-2034)

8 Japan Influenza Diagnostics Market - Breakup by Type of Flu

  • 8.1 Type A Flu
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Type B Flu
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Type C Flu
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)

9 Japan Influenza Diagnostics Market - Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Others
    • 9.3.1 Historical and Current Market Trends (2020-2025)
    • 9.3.2 Market Forecast (2026-2034)

10 Japan Influenza Diagnostics Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Product
    • 10.1.4 Market Breakup by Test Type
    • 10.1.5 Market Breakup by Type of Flu
    • 10.1.6 Market Breakup by End User
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kansai/Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Product
    • 10.2.4 Market Breakup by Test Type
    • 10.2.5 Market Breakup by Type of Flu
    • 10.2.6 Market Breakup by End User
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Product
    • 10.3.4 Market Breakup by Test Type
    • 10.3.5 Market Breakup by Type of Flu
    • 10.3.6 Market Breakup by End User
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Product
    • 10.4.4 Market Breakup by Test Type
    • 10.4.5 Market Breakup by Type of Flu
    • 10.4.6 Market Breakup by End User
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Product
    • 10.5.4 Market Breakup by Test Type
    • 10.5.5 Market Breakup by Type of Flu
    • 10.5.6 Market Breakup by End User
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Product
    • 10.6.4 Market Breakup by Test Type
    • 10.6.5 Market Breakup by Type of Flu
    • 10.6.6 Market Breakup by End User
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Product
    • 10.7.4 Market Breakup by Test Type
    • 10.7.5 Market Breakup by Type of Flu
    • 10.7.6 Market Breakup by End User
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Product
    • 10.8.4 Market Breakup by Test Type
    • 10.8.5 Market Breakup by Type of Flu
    • 10.8.6 Market Breakup by End User
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Influenza Diagnostics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Influenza Diagnostics Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix